Filters
Term Search
You can select from the dropdown list OR enter your own terms to refine the search.
Last Updated: 10/31/2025
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications
Unveiling the Potential of Zenocutuzumab: A Breakthrough in NSCLC and Pancreatic Adenocarcinoma Treatment.
Journal: Oncology (Williston Park, N.Y.)
Published: August 20, 2025
Bispecific Antibodies in Non-Small Cell Lung Cancer: From Targeted Innovation to Real-World Integration.
Journal: American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting
Published: May 21, 2025
Emerging importance of HER3 in tumorigenesis and cancer therapy.
Journal: Nature reviews. Clinical oncology
Published: February 24, 2025
Zenocutuzumab shows efficacy in NRG1 fusion-positive solid tumours.
Journal: Nature reviews. Clinical oncology
Published: February 20, 2025
Efficacy of Zenocutuzumab in NRG1 Fusion-Positive Cancer.
Journal: The New England journal of medicine
Published: February 05, 2025
Zenocutuzumab (Bizengri) for NSCLC and pancreatic adenocarcinoma.
Journal: The Medical letter on drugs and therapeutics
Published: January 17, 2025
The use of zenocutuzumab for NRG1 fusion-positive tumors.
Journal: Clinical advances in hematology & oncology : H&O
Published: January 17, 2025
Novel drugs approved by the EMA, the FDA and the MHRA in 2024: A year in review.
Journal: British journal of pharmacology
Published: January 03, 2025
The phase I/II eNRGy trial: Zenocutuzumab in patients with cancers harboring NRG1 gene fusions.
Journal: Future oncology (London, England)
Published: February 13, 2024
Last Updated: 10/31/2025